Connecticut et al v. Sandoz, Inc. et al
Case Number:
3:20-cv-00802
Court:
Nature of Suit:
Judge:
Firms
- Armstrong Teasdale
- Arnold & Porter
- Bailey Duquette
- Baker Botts
- Clifford Chance
- Cole Schotz
- Competition Law Partners
- Day Pitney
- Debevoise & Plimpton
- Dechert LLP
- DLA Piper
- Faegre Drinker
- Gage Spencer & Fleming
- Harris Beach Murtha Cullina PLLC
- Hinckley Allen
- Hogan Lovells
- Kelley Drye
- Linklaters LLP
- Mintz Levin
- Morgan Lewis
- Morrison & Foerster
- Norton Rose
- O'Toole & O'Toole
- Petrillo Klein
- Proskauer Rose
- Ropes & Gray
- Saul Ewing
- Saxton & Stump
- Shapiro Arato
- Skadden Arps
- Troutman
- Wiggin & Dana
- Wilson Sonsini
Companies
- Allergan PLC
- Amneal Pharmaceuticals Inc.
- Aurobindo Pharma Ltd.
- Bausch Health Cos. Inc.
- Fougera Pharmaceuticals Inc.
- Glenmark Pharmaceuticals Ltd.
- G&W Laboratories Inc.
- Lannett Company, Inc
- Lupin Ltd.
- Mallinckrodt PLC
- Optum Inc.
- OptumRx Inc.
- Perrigo Co. PLC
- Pfizer Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Wockhardt USA LLC
Government Agencies
- Commonwealth of Kentucky
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
- ← Previous
- 1
- 2
- 3
- 4
- Next →